cancer

Keryx and AEterna Zentaris say perifosine improved survival compared to potential competitor
Yahoo/AP
Mon, 01/25/10 - 03:57 pm
Aeterna Zentaris
Keryx
cancer
perifosine
Geron reports anticancer activity in preclinical study on developing drug imetelstat
Yahoo/AP
Tue, 01/5/10 - 12:13 pm
Geron
cancer
imetelstat
Dynavax wraps up Symphony Dynamo deal
Bizjournals.com
Mon, 01/4/10 - 02:17 pm
Dynavax
Symphony Dynamo
cancer
Good News for Vical Candidate
Yahoo/Zacks.com
Wed, 12/30/09 - 05:18 pm
Vical
FDA
cancer
Allovectin-7
Cell Therapeutics adopts 'poison pill' plan
Yahoo/AP
Mon, 12/28/09 - 10:13 am
poison pill
Cell Therapeutics
FDA
cancer
pixantrone
FDA Says 'Unlikely' That Vytorin, Zetia Increase Cancer Risk
WSJ Online
Tue, 12/22/09 - 04:09 pm
Vytorin
Zetia
cancer
FDA
Celgene's Revlimid meets cancer study goal
Yahoo/AP
Fri, 12/18/09 - 10:43 am
Revlimid
cancer
Celgene
clinical trials
Multiple Myeloma
Millennium strikes $365M deal for Seattle Genetics' cancer antibody
Fierce Biotech
Tue, 12/15/09 - 09:25 am
Seattle Genetics
Millennium
antibodies
cancer
Merck Starts China Trial of Cancer Vaccine
Seeking Alpha
Mon, 12/14/09 - 07:35 am
cancer
Merck
China
vaccines
Stimuvax
Glaxo hands back another cancer drug to Cytokinetics
Fierce Biotech
Thu, 12/10/09 - 11:08 am
Cytokinetics
GSK
cancer
Lilly Plans Two New Drugs a Year Starting in 2013, China Focus
Bloomberg
Thu, 12/10/09 - 08:31 am
China
Eli Lilly
pipelines
Alzheimer's disease
diabetes
cancer
Isis reacquires rights to drug, will revamp cancer program
San Diego Union Tribune, CA
Wed, 12/9/09 - 10:12 am
Isis Pharmaceuticals
Eli Lilly
cancer
Novartis seeks to broaden use of some cancer drugs
Marketwatch
Wed, 12/9/09 - 09:58 am
cancer
Novartis
Tasigna
Zometa
Novartis' Cancer Plan
Forbes
Tue, 12/8/09 - 11:10 am
cancer
Novartis
Tasigna
Gleevac
Afinitor
Onyx Treatment Fights Cancer With Few Side Effects
Bloomberg
Mon, 12/7/09 - 05:40 pm
ONYX Pharmaceuticals
cancer
Multiple Myeloma
Immunogen lifted by cancer-drug trial
Bizjournals.com
Mon, 12/7/09 - 12:47 pm
Immunogen
cancer
drug trials
Introducing the $30,000 Per Month Cancer Drug
WSJ Online
Mon, 12/7/09 - 12:21 pm
cancer
Folotyn
lymphoma
Allos
Cephalon’s Treanda Poised for 10-Fold Sales Surge
Bloomberg
Mon, 12/7/09 - 11:33 am
Cephalon
Treanda
cancer
Keryx Biopharmaceuticals cancer drug candidate gets faster regulatory review by FDA
Yahoo/AP
Wed, 12/2/09 - 10:03 am
FDA
Keryx
perifosine
cancer
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
Mon, 11/30/09 - 11:05 am
Celgene
JNJ
cancer
Revlimid
Velcade

Pages